Evidence map›Paper›PMID 40970241›Full record

ArticleNanophotonics (Berlin, Germany)2025

Enhancement of second-harmonic generation through Brillouin zone folding in a waveguide-coupled metasurface.

Tsafrir Abir, Tal Ellenbogen

Abstract read
In one paragraph

Article in Nanophotonics (Berlin, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Tsafrir AbirRaymond and Beverly Sackler Faculty of Exact Sciences, School of Physics and Astronomy, Tel-Aviv University, Tel-Aviv, 6779801, Israel.ORCID https://orcid.org/0000-0002-6609-3655
Tal EllenbogenCenter for Light-Matter Interaction, Tel-Aviv University, Tel-Aviv, 6779801, Israel.ORCID https://orcid.org/0000-0002-0083-9290

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metasurfaces have become significant platforms for optical manipulation, yet unlocking their full potential for nonlinear optics requires novel mechanisms to control and enable frequency conversion processes. This study demonstrates how structural dimerization in plasmonic metasurfaces coupled to waveguides can modify linear and nonlinear optical behavior via Brillouin zone folding. By introducing a centrosymmetric unit cell design featuring two mirrored split-ring resonators, we allow guided modes that were previously below the light line to appear as guided-mode resonances. These resonances facilitate nonlocal modes, which are present as distinct narrow transparency windows. Although centrosymmetric dimerized design typically forbids far-field radiation through quadratic nonlinear interactions, we observe notable second-harmonic generation - not merely through symmetry breaking at oblique incidence, which proves insufficient, but rather with the support of a nonlocal mode. The excitation of a collective mode at the pump frequency provides a strong nonlinear response by mediating the formation of a net dipole moment at the second-harmonic frequency, enabling far-field radiation that is otherwise forbidden. This synchronized action among split-ring resonators leads to observable second-harmonic generation, confirmed by both experimental evidence and simulations. Our results indicate that dimerized metasurfaces represent a versatile platform for harnessing collective modes in nonlinear interactions. This motivates further research and suggests promising applications in advanced nonlinear photonic devices.

Indexed as

dimerized metasurfaceguided mode resonancelattice resonancesnonlinearnonlocalplasmonic

Identifiers

PMID40970241
PMCPMC12442358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.